Can I read ROS1-Positive NSCLC Treatment Protocol on EtoBox?

ROS1-Positive NSCLC Treatment Protocol by ELFinch is a document available to read on EtoBox.

What is ROS1-Positive NSCLC Treatment Protocol about?

The BC Cancer Protocol LUAVENT outlines the first-line treatment of ROS1-positive advanced non-small cell lung cancer (NSCLC) using entrectinib for eligible patients. Key eligibility criteria include stage IIIB or IV NSCLC with confirmed ROS1 positivity and no prior systemic therapy, while exclusions include significant cardiac issues. The protocol details treatment administration, monitoring requirements, dose modifications, and precautions related to potential side effects.

Author

ELFinch

Language

EN